Use of antifoams in drug metabolism studies in vitro.
D000336:Aerosols; D000814:Aniline Compounds / Q000032:analysis; D000818:Animals; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D003579:Cytochrome Reductases / Q000032:analysis; D003902:Detergents / Q000494:pharmacology*; D004655:Emulsions; D006591:Hexobarbital / Q000494:pharmacology; D066298:In Vitro Techniques; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology; D051381:Rats; D012828:Silicones / Q000494:pharmacology; D013053:Spectrophotometry; D013501:Surface-Active Agents / Q000494:pharmacology*; D013997:Time Factors
D000336:Aerosols; D000814:Aniline Compounds; D003902:Detergents; D004655:Emulsions; D012828:Silicones; D013501:Surface-Active Agents; D003577:Cytochrome P-450 Enzyme System; D006591:Hexobarbital; D003579:Cytochrome Reductases